Catalan Institute of Nanoscience and Nanotechnology (ICN2) The Barcelona Institute
of Science and Technology, Barcelona, Spain
Dr. Daniel Maspoch is an ICREA Research Professor and Leader of the Supramolecular
NanoChemistry & Materials Group at ICN2.
He is a chemist who has always maintained a rewarding balance between fundamental
and applied research, with pioneering developments in the field of porous metal/covalent-organic
frameworks and delivery systems. He is author of over 140 manuscripts and 6 book chapters.
In addition, in 2014 he got a prestigious ERC Consolidator Grant and, in 2019, a ERC-POC.
In 2015, he was awarded the Premio Marcial Moreno Mañas Lectureship.
From the technology transfer side, several technologies and materials developed by
his group have been transferred –through licensing patents or signing technology transfer
contracts– to various companies. More specifically, Daniel has signed more than 17
research contracts with private companies and has filed 10 patents, from which 4 have
been licensed. Moreover, he has been able to signed 4 technology transfer contracts.
Interestingly, these technologies have given rise to families of products that are
now on the market, as for example LuctaCaps® and Fungipol@CP. He is also co-founder
of the spin-off company Ahead Therapeutics.
Dr. Maspoch graduated in Chemistry at the Universitat de Girona and obtained his PhD
in Materials Science at the Universitat Autònoma de Barcelona & Institut de Ciència
de Materials de Barcelona. He then moved to Northwestern University, where he worked
as a postdoctoral fellow in the group of Prof. Chad A. Mirkin. Since September 2011
he is ICREA Research Professor and Group Leader at the Institut Català de Nanociència
i Nanotecnologia (ICN2).
General Enquiries and Location
Thank you for your interest, For further information on the Global Science Summit 2020, please contact the following: